IPOs, Initial Public Offerings: pre & post IPO

KDMN (Kadmon Holdings) Tuesday Night

Print this entry

While there was a lot of initial hype on this IPO 2 years ago demand in the biotech IPO market has waned considerably. Sam Waksal founded the company in 2010 but has recently sold his stake for 25mm. We are hearing of no demand with in the 16-20 range and the large biotech funds are currently not in the books.





Leave a Reply



Lost your password?